| Literature DB >> 30526643 |
Xieling Chen1, Ziqing Liu2, Li Wei3, Jun Yan4, Tianyong Hao5, Ruoyao Ding6.
Abstract
BACKGROUND: The application of artificial intelligence techniques for processing electronic health records data plays increasingly significant role in advancing clinical decision support. This study conducts a quantitative comparison on the research of utilizing artificial intelligence on electronic health records between the USA and China to discovery their research similarities and differences.Entities:
Keywords: Artificial intelligence; Bibliometrics; China; Electronic health records; Topic modelling; United States
Mesh:
Year: 2018 PMID: 30526643 PMCID: PMC6284279 DOI: 10.1186/s12911-018-0692-9
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Search keywords related to “artificial intelligence” and “EHR”
| Keywords related to “artificial intelligence” | “artificial intelligence” OR “intelligent information processing” OR “machine learning” OR “pattern recognition” OR “information retrieval” OR “information extraction” OR “data mining” OR “text mining” OR “deep learning” OR “neural network” OR “natural language processing” OR “NLP” OR “semantic analysis” OR “question answering” OR “word sense disambiguation” OR “named entity recognition” OR “language modeling” OR “intelligent computing” OR “intelligent computation” OR “speech recognition” OR “smart learning” OR “knowledge graph” OR “automated reasoning” OR “automated inference” OR “knowledge representation” OR “fuzzy logic” OR “bayesian network” OR “machine intelligence” OR “natural language generation” OR “natural language understanding” OR “bayesian networks” OR “neural networks” OR “classification algorithm” OR “clustering algorithm” OR “association rule mining” |
| Keywords related to “EHRs” | “electronic medical record” OR “clinical notes” OR “clinical summary” OR “discharge summary” OR “EMR” OR “medical data” OR “electronic patient record” OR “medical record” OR “medical records” OR “electronic medical records” OR “electronic health record” OR “EHR” OR “electronic health records” OR “EHRs” OR “EMRs” OR “clinical note” OR “electronic patient records” OR “personal health record” |
Fig. 1The distributions of total publications by year
Prolific publication sources
| R | Prolific publication sources for the USA | TP | P% | R | Prolific publication sources for China | TP | P% |
|---|---|---|---|---|---|---|---|
| 1 |
| 135 | 13.09 | 1 |
| 13 | 7.51 |
| 2 |
| 96 | 9.31 | 2 |
| 6 | 3.47 |
| 3 |
| 65 | 6.30 | 3 |
| 6 | 3.47 |
| 4 |
| 29 | 2.81 | 4 |
| 6 | 3.47 |
| 5 |
| 28 | 2.72 | 5 |
| 5 | 2.89 |
| 6 |
| 27 | 2.62 | 6 |
| 5 | 2.89 |
| 7 |
| 20 | 1.94 | 7 |
| 5 | 2.89 |
| 8 |
| 19 | 1.84 | 8 |
| 5 | 2.89 |
| 9 |
| 18 | 1.75 | 9 |
| 4 | 2.31 |
| 10 |
| 14 | 1.36 | 10 |
| 4 | 2.31 |
| 11 |
| 12 | 1.16 | 11 |
| 4 | 2.31 |
| 12 |
| 10 | 0.97 | 12 |
| 4 | 2.31 |
| 13 |
| 9 | 0.87 | 13 |
| 4 | 2.31 |
| 14 |
| 8 | 0.78 | 14 |
| 4 | 2.31 |
| 15 |
| 8 | 0.78 | ||||
| 16 |
| 8 | 0.78 |
Top prolific authors
| the USA | China | ||||||
|---|---|---|---|---|---|---|---|
| Rank | Name | Country | TP | Rank | Name | Country | TP |
| 1 |
| the USA | 53 | 1 |
| China | 7 |
| 2 |
| the USA | 36 | 2 |
| China | 6 |
| 3 |
| the USA | 34 | 3 |
| China | 4 |
| 4 |
| the USA | 32 | 4 |
| China | 4 |
| 5 |
| the USA | 28 | 5 |
| China | 4 |
| 6 |
| the USA | 22 | 6 |
| China | 4 |
| 7 |
| the USA | 21 | 7 |
| China | 4 |
| 8 |
| the USA | 20 | 8 |
| China | 4 |
| 9 |
| the USA | 19 | 9 |
| China | 4 |
| 10 |
| the USA | 18 | 10 |
| China | 4 |
| 11 |
| the USA | 18 | 11 |
| China | 4 |
Top prolific affiliations
| Rank | Name | Country | TP | Rank | Name | Country | TP |
|---|---|---|---|---|---|---|---|
| 1 |
| the USA | 101 | 1 |
| China | 12 |
| 2 |
| the USA | 96 | 2 |
| China | 10 |
| 3 |
| the USA | 93 | 3 |
| China | 9 |
| 4 |
| the USA | 82 | 4 |
| China | 8 |
| 5 |
| the USA | 72 | 5 |
| China | 8 |
| 6 |
| the USA | 63 | 6 |
| China | 7 |
| 7 |
| the USA | 53 | 7 |
| China | 7 |
| 8 |
| the USA | 48 | 8 |
| China | 6 |
| 9 |
| the USA | 48 | 9 |
| China | 6 |
| 10 |
| the USA | 43 | 10 |
| China | 6 |
Fig. 2Geographical distributions of the publications in the USA
Fig. 3Geographical distributions of the publications in China
Regional distributions of publications
| Country | the USA | China | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2008–2017 | 2008–2012 | 2013–2017 | 2008–2017 | 2008–2012 | 2013–2017 | ||||||
| Rank | Region | Num. | Region | Num. | Region | Num. | Region | Num. | Region | Num. | Region | Num. |
| 1 | Massachusetts | 211 | New York | 45 | Massachusetts | 169 | Taiwan | 47 | Taiwan | 15 | Beijing | 38 |
| 2 | New York | 173 | Massachusetts | 42 | California | 129 | Beijing | 46 | Beijing | 8 | Taiwan | 32 |
| 3 | California | 161 | Minnesota | 37 | New York | 128 | Guangdong | 22 | Hong Kong | 3 | Guangdong | 21 |
| 4 | Minnesota | 122 | Tennessee | 36 | Minnesota | 85 | Shanghai | 17 | Sichuan | 3 | Shanghai | 16 |
| 5 | Tennessee | 102 | California | 32 | Pennsylvania | 81 | Zhejiang | 16 | Zhejiang | 3 | Zhejiang | 13 |
| 6 | Pennsylvania | 98 | Utah | 27 | Texas | 68 | Jiangsu | 11 | Heilongjiang | 2 | Jiangsu | 10 |
| 7 | Utah | 90 | Maryland | 17 | Tennessee | 66 | Heilongjiang | 9 | Macau | 2 | Hubei | 8 |
| 8 | Maryland | 81 | Pennsylvania | 17 | Maryland | 64 | Hubei | 8 | Chongqing | 1 | Heilongjiang | 7 |
| 9 | Texas | 78 | Washington | 16 | Utah | 63 | Chongqing | 7 | Gansu | 1 | Chongqing | 6 |
| 10 | Washington | 72 | Indiana | 14 | Washington | 56 | Sichuan | 7 | Guangdong | 1 | Henan | 5 |
| 11 | Illinois | 51 | Wisconsin | 13 | Ohio | 42 | Hong Kong | 6 | Jiangsu | 1 | Macau | 4 |
| 12 | Indiana | 45 | Illinois | 11 | Illinois | 40 | Macau | 6 | Shaanxi | 1 | Sichuan | 4 |
| 13 | Ohio | 45 | Florida | 10 | Indiana | 31 | Henan | 5 | Shandong | 1 | Hong Kong | 3 |
| 14 | Michigan | 38 | Michigan | 10 | Michigan | 28 | Shaanxi | 4 | Shanghai | 1 | Jilin | 3 |
Fig. 4Sketch map of collaboration patterns reflected by CAI
Fig. 5Annual collaboration degree distributions
Fig. 6Collaboration network in country level for the USA’s publications
Fig. 7Left: estimated α value for the models fitted using VEM. Right: perplexities of the test data for the models fitted by using Gibbs sampling. Each line corresponded to one of the folds in the 10-fold cross-validation for the USA’s publications
Fig. 8Left: estimated α value for the models fitted using VEM. Right: perplexities of the test data for the models fitted by using Gibbs sampling. Each line corresponded to one of the folds in the 10-fold cross-validation for China’s publications
15 selected top terms for the top 5 best matching topics
| Country | Topic | Potential theme | Top high frequency terms |
|---|---|---|---|
| the USA | 3 | Drug adverse event | Drug; Adverse; Reaction; Pharmacovigilance; Safety; Signal; Adverse drug event; Interaction; allergy; Surveillance; Drug-drug; Spontaneous; Adverse drug reaction; Food and drug administration; Drug-drug interaction |
| 31 | Vaccine | Vaccine; Safety; Adverse; Surveillance; Influenza; Vaccine adverse event reporting system; Adverse Even; Syndromic; Immunization; Emergency; Inactivated; Drug; Post-licensure; Anaphylaxis; Injection | |
| 30 | Diabetes mellitus | Diabetes; Mellitus; Diabetic; Ensemble; Visualization; Deterioration; Fit; Neural; Type 2 diabetes mellitus; Insulin; Support vector machine; Warning; Metformin; Glucose; Nephropathy | |
| 27 | Health data confidentiality | De-identification; Annotation; Corpus; Protected health information; Privacy; Annotator; Confidentiality; Comorbidity; Portability; Obesity; Security; Track; Anonymization; Veterans health administration; Health insurance portability and accountability act | |
| 18 | Health data analysis technique | Semantic; Terminology; Ontology; Similarity; Biomedical; Unified medical language system; Corpus; Mapping; Topic; Redundancy; Lexicon; Reasoning; Relatedness; Lexical; Nomenclature | |
| China | 33 | Named entity recognition | Chinese; Entity; Word; Note; Discharge; Embedding; Annotation; Segmentation; Negation; Speculation; Conditional; Named entity recognition; Character; Deep; F-measure |
| 23 | Drug adverse event | Risk; Statin; Adverse; Discontinuation; Cardiovascular; Event; Reaction; Heart; Coronary; Drug; Lipid-lowering; Medication; Therapy; Artery; Cardiovascular disease | |
| 30 | Smoking | Smoking; Mental; Status; Prevalence; Electric; Aged; Disorder; Open-text; Hybrid electric vehicle; CRIS-IE-Smoking; Electronic health record; Fuzzy; Logic; Bipolar; Male | |
| 26 | Prescription & drug | Prescription; Symptom; Medicine; Aspirin; Chinese; Knowledge base; Medication; Drug; Protective; Similarity; Diarrhoea; Gastrointestinal; Low-dose; Mucoprotective drug; Regularity | |
| 14 | Risk event | Congestive heart failure; Drug; Risk; Web-based; Health information exchange; Chronic; Emergency department; Deficiency; Cluster; Failure; Gastritis; Real-time; Congestive; Heart; Children of severe hand, foot, and mouth disease |
Fig. 9AP clustering result of the identified clusters for the USA’s publications
Fig. 10AP clustering result of the identified clusters for China’s publications
Fig. 11The trends of research topics for the USA’s publications
Fig. 12The trends of research topics for China’s publications